SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company’s third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be … [Read more…]
NAARDEN, Netherlands & WALTHAM, Mass.–(BUSINESS WIRE)–Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced the appointment of Anne Sullivan as Chief Business Officer. In this role, Ms. Sullivan will lead all strategic collaboration activities. “As Prilenia … [Read more…]
NORTHFIELD, N.H.–(BUSINESS WIRE)–EPTAM Precision Solutions (“EPTAM” or the “Company”), a Frazier Healthcare Partners (“Frazier”) portfolio company, is pleased to announce the acquisition of Sterling Manufacturing (“Sterling”) and their wholly-owned subsidiary Albright Silicone (“Albright”). Sterling is a component manufacturer headquartered in Lancaster, MA specializing in plastic injection molding and Liquid Silicone Rubber (LSR) molding serving the … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–#MOA—Meliora Therapeutics, a biotech company pioneering a machine learning-driven platform to decipher oncology drugs’ true mechanisms-of-action, announced today the close of an $11M seed financing round led by HOF Capital and ZhenFund, with participation from Obvious Ventures, Village Global, BrightEdge (the impact investment arm of the American Cancer Society), Pebblebed (fund of … [Read more…]
Internationally renowned healthcare leader, physician, innovator, author and speaker to foster performance improvement for Press Ganey clients CHICAGO–(BUSINESS WIRE)–Press Ganey, the renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem, announced today the appointment of Amy Compton-Phillips, MD, as President and Chief Clinical Officer of the Press Ganey consulting division. Dr. … [Read more…]
OSAKA, Japan, & GENEVA, Switzerland–(BUSINESS WIRE)–As part of their well-established partnership, the United Nations Institute for Training and Research (UNITAR) and Takeda (TSE:4502/NYSE:TAK), a global pharmaceutical leader and an active member of the United Nations Global Compact, are pleased to announce a new joint initiative focused on strengthening countries’ healthcare systems to meet patients’ need … [Read more…]
CareDx Top-Tier Sponsor for Heart Failure Society of America Annual Scientific Meeting BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will host a symposium to describe the latest innovations in post-cardiac … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Devices Market Research Report by Devices (Diagnosis Devices, Surgical Devices, and Vision Care), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmology Devices Market size was estimated at USD 59.85 billion … [Read more…]
Will brings a strong track record of creating value through company-building, deep relationships with capital markets and rare disease drug development and commercialization experience Other appointments include VP of Business Development and VP of U.S. Operations to oversee global clinical and regulatory operations Company advancing several synthetic rescue-based programs for intractable genetic diseases, both in-house … [Read more…]
Retail Comparable Store Prescriptions Increased 3.1 Percent – Comparable Store Acute Prescriptions, Excluding COVID Immunizations, Increased 5.3 Percent Revenues of $5.9 billion, Compared to Prior Year Revenues of $6.1 billion Net Loss per Share of $6.07, Compared to the Prior Year Net Loss per Share of $1.86 Driven by Non-Cash Goodwill Impairment Charge Adjusted Net … [Read more…]
